A. Virga, C. Gianni, M. Palleschi, F. Merloni, R. Maltoni, P. Ulivi, U. De Giorgi, G. Martinelli, S. Bravaccini
{"title":"在接受激素疗法和 CDK4/6 抑制剂治疗的激素受体阳性 (HR+)/HER2- 晚期乳腺癌患者血浆中,通过新型 ctDNA 检测法检测 AKT1、ERBB2、ESR1、KRAS、PIK3CA 和 TP53 的改变","authors":"A. Virga, C. Gianni, M. Palleschi, F. Merloni, R. Maltoni, P. Ulivi, U. De Giorgi, G. Martinelli, S. Bravaccini","doi":"10.1016/j.ejca.2024.113807","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"449 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AKT1, ERBB2, ESR1, KRAS, PIK3CA and TP53 alteration detection by a new ctDNA assay in plasma of patients with hormone receptor positive (HR+)/HER2- advanced Breast Cancer treated with hormonal therapy and CDK4/6 inhibitors\",\"authors\":\"A. Virga, C. Gianni, M. Palleschi, F. Merloni, R. Maltoni, P. Ulivi, U. De Giorgi, G. Martinelli, S. Bravaccini\",\"doi\":\"10.1016/j.ejca.2024.113807\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505596,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"449 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejca.2024.113807\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ejca.2024.113807","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
AKT1, ERBB2, ESR1, KRAS, PIK3CA and TP53 alteration detection by a new ctDNA assay in plasma of patients with hormone receptor positive (HR+)/HER2- advanced Breast Cancer treated with hormonal therapy and CDK4/6 inhibitors